Home / Events / Swiss Biotech Day 2024
Basel city scape
Commercial

Swiss Biotech Day 2024

Basel, Switzerland

The Swiss Biotech Day is a premier biotechnology conference in Europe, attracting professionals from the global life sciences community - providing a platform for networking and the exploration of advancements in R&D, manufacturing, data management, artificial intelligence, and innovative financing.

Discussion Overview

We all know there is money to spend in biopharma, but competition is tough and the risks are higher in a more unpredictable market. Expert panelists discuss why it is critical to see biopharma investment pick up in 2024. Does big pharma have a moral obligation to fill the early-stage funding gaps? Are VCs ready to place big biotech bets?

Coverage from the event

''

NASDAQ Is Nice But Home Provides Comfort For Europe’s Biotechs

''

Pharma Happy To Be Custodian For Innovative Science From Cash-Strapped Biotechs

Meet the panelists
Headshot of Dan Chancellor.
Dan Chancellor
Director of Thought Leadership & Consulting
Citeline, UK based
M Altorfer
Michael Altorfer
CEO of
Swiss Biotech Association
K Grogan
Kevin Grogan
Managing Editor, Scrip
Citeline
Dan Chancellor
Director of Thought Leadership & Consulting
 Citeline, UK based
Dan is a pharma industry generalist, covering topics including COVID-19, immuno-oncology, tumor-agnostic drug development, artificial intelligence and M&A.
Michael Altorfer
CEO of
 Swiss Biotech Association
Dr. Michael Altorfer is the CEO of the Swiss Biotech Association. He has more than 20 years of experience in the life science industry comprising both big pharma and smaller biotech organizations.
Kevin Grogan
Managing Editor, Scrip
 Citeline
Kevin Grogan, the Managing Editor for Europe at Citeline, is a seasoned journalist with extensive experience covering various aspects of the pharmaceutical industry and therapeutic areas. Based in Manchester, UK, Kevin has interviewed prominent figures within the sector. His expertise extends to financial and medical conferences, where he actively participates as a moderator. Kevin’s insights have also been featured on BBC television, radio, ITV, and Channel 4, where he discusses industry-related topics.

Curated insights for Swiss Biotech Atendees

Preview of the Commercial Solutions Citeline offers.
Informational Flyer
Commercial

Explore our Commercial Solutions

We transform data into action. For an overview of our Commercial solutions portfolio, check out our flyer.

Web page preview of the The Biopharma A List article.
Article
Commercial

The Biopharma A List: Taking The Pulse Of Newco Creation

On the new company creation front, using Series A financings as a proxy, start-ups have not escaped the challenging funding environment. Here we update trends in those first-time rounds for 2023.

Webinar announcement featuring the panelists.
Webinar
Commercial

Deal-Making: Scouting for Expertise Webinar with Ipsen

Catch up with Ipsen and Citeline to hear the latest for deal-making, cutting through the noise to find the right deal and securing competitive alliances.